| --- | --- | |-------|---------------------------------------------------------------------| | | | | | | | | | | | | | | Immunic Therapeutics Developing Selective Oral Drugs in Immunology | | | NASDAQ: IMUX February 2020 | Cautionary Note Regarding Forward-Looking Statements • Certain statements contained in this presentation regarding matters that are not historical facts are forward-looking statements within the meaning of Section 21E of the Securities and Exchange Act of 1934, as amended, and the Privat ...